ALLISON RASNIC: Open Payments
NPI 1376295097 · JACKSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,562 in 61 payments from 33 companies in 2025. Trend: 2023 $404 · 2024 $507 · 2025 $1,562
Food & beverage: $1,378Education: $184
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 8 | $230 |
| Merck Sharp & Dohme LLC | 6 | $158 |
| AstraZeneca Pharmaceuticals LP | 2 | $150 |
| Astellas Pharma US Inc | 2 | $106 |
| Janssen Biotech, Inc. | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
| PFIZER INC. | 3 | $61 |
| Aveo Pharmaceuticals, Inc. | 2 | $59 |
| E.R. Squibb & Sons, L.L.C. | 3 | $47 |
| SpringWorks Therapeutics, Inc. | 2 | $43 |
Products named: Enhertu, LYNPARZA, FOTIVDA, KISQALI, INJECTAFER, KEYTRUDA, OPDIVO, BRUKINSA.
Industry payments across TN — which companies pay providers there.
